BJL
NAUT icon

Brighton Jones LLC’s Nautilus Biotechnolgy NAUT Stock Holding History

Brighton Jones LLC’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-43,961
Closed -$93K – 504
2022
Q3 		$93K Sell
43,961
-283
-0.6% -$712 0.01% 443
2022
Q2 		$119K Buy
+44,244
New +$165K 0.01% 447
2021
Q2 		– Sell
-10,000
Closed -$138K – 492
2021
Q1 		$138K Buy
+10,000
New +$139K 0.01% 417

Other funds holding NAUT

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $329M AUM 64.12% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $4.42B AUM 22.6% 1-Year Est. Return
AI
ArchPoint Investors Coral Gables, Florida $473M AUM 49.24% 1-Year Est. Return

Brighton Jones LLC's NAUT Position: Q4 2022 in Review

Brighton Jones LLC sold out of Nautilus Biotechnolgy (NAUT) in Q4 2022, closing a stake of 43,961 shares — an estimated $93K sold.

Brighton Jones LLC first reported a position in NAUT in Q1 2021 and held it in 3 quarters. The position peaked at $138K in Q1 2021. 81 funds tracked by Wall St. Rank hold NAUT as of Q4 2022.

  • Brighton Jones LLC reported no remaining Nautilus Biotechnolgy position as of Q4 2022 after selling out during the quarter.
  • Brighton Jones LLC sold 43,961 Nautilus Biotechnolgy shares in Q4 2022, an estimated $93K.
  • Brighton Jones LLC first reported a position in Nautilus Biotechnolgy in Q1 2021 and held it in 3 quarters.
  • Brighton Jones LLC's Nautilus Biotechnolgy position peaked at $138K in Q1 2021.
  • 81 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q4 2022.

Based on Brighton Jones LLC's 13F filing for Q4 2022, filed 3 Feb 2023.